Addus HomeCare (NASDAQ:ADUS) Downgraded by Wall Street Zen to Buy

Addus HomeCare (NASDAQ:ADUS) was downgraded by research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Sunday.

Several other equities analysts also recently commented on the company. Truist Financial set a $135.00 price objective on Addus HomeCare and gave the company a “buy” rating in a research note on Wednesday, January 7th. Barclays upped their price target on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research report on Tuesday, November 4th. Royal Bank Of Canada lifted their price objective on Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. TD Cowen restated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $135.44.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $110.37 on Friday. The firm has a market cap of $2.04 billion, a P/E ratio of 23.63, a P/E/G ratio of 1.32 and a beta of 0.92. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66. Addus HomeCare has a 52 week low of $88.96 and a 52 week high of $134.64. The firm’s fifty day moving average is $112.24 and its 200-day moving average is $113.18.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. The firm had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The business’s revenue was up 25.0% compared to the same quarter last year. During the same period last year, the business posted $1.30 EPS. Equities analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Darby Anderson sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the sale, the executive vice president owned 44,144 shares of the company’s stock, valued at approximately $4,811,696. This represents a 31.18% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders have sold a total of 20,316 shares of company stock worth $2,215,998 over the last three months. 4.50% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its stake in Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after buying an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Addus HomeCare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Addus HomeCare by 6.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after purchasing an additional 2,952 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of Addus HomeCare by 387.6% during the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after purchasing an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC grew its holdings in shares of Addus HomeCare by 44.7% during the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after purchasing an additional 4,439 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.